Obesity

SEP 9, 2026 · PHASE 2 TRIAL

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

ClinicalTrials.gov

Phase 2 trial with completed enrollment but no results posted; design and primary outcome are specified but efficacy and safety data are not yet reported in this registry record.

SEP 9, 2026 · PHASE 1 TRIAL

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

ClinicalTrials.gov

Phase 1 safety study with no posted results; registry record describes planned conduct only, not outcomes.

SEP 9, 2026 · PHASE 3 TRIAL

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and outcomes have not yet been reported.

SEP 9, 2026 · PHASE 1 TRIAL

A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

ClinicalTrials.gov

This is a Phase 1 clinical trial registry record with no results posted; it describes a planned safety and drug-drug interaction study in a small healthy population.

SEP 8, 2026 · INTERVENTIONAL STUDY

tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity

ClinicalTrials.gov

This is a planned interventional trial with no results posted; enrollment is ongoing and primary outcomes are not yet reported.

SEP 8, 2026 · OBSERVATIONAL STUDY

The Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for Obesity

ClinicalTrials.gov

This is a completed observational study registration with no reported results, designed to characterize eating behavior and food preference phenotypes as obesity risk factors in a specific population.

SEP 8, 2026 · OBSERVATIONAL STUDY

Inflammation, Diabetes, Ethnicity and Obesity Cohort

ClinicalTrials.gov

This is a registry record for an ongoing observational cohort study with no results reported; it describes planned enrollment and data collection only.

SEP 8, 2026 · PHASE 3 TRIAL

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

ClinicalTrials.gov

This is an active Phase 3 trial registration with no results posted; the study design and primary endpoints are defined but efficacy and safety data are not yet available.